Page 103 - Annual Report 2022-23
P. 103
Sponsored Research
Sponsored Research
Funds
Funding
S.No Project Title PI / CoPI provided (INR
Agency
in lakh)
The effect fo acquired bacterial
mutations on metabolism and fitness
of multi-drug resistant pathogenic Dr.Anand A,
37 ICMR 23.90
bacteria by genomics,systems Co.PI:Dr.Sudha Ramaiah
biology,and machine learning
approaches.
On-package enzyme based
halochromic time temperature Dr. Ramalingam C,
38 DRDO 37.41
indicators for shelf-life of refrigerated Co.PI:Dr. Senthil Kumar A
perishable foods.
An efficient high-order accurate DST-SERB-
39 parallel solver for large eddy Dr. Sekarapandian N CRG 11.35
simulation of turbulent flows
Nature inspired sugar derived
biomimetic polymers for capturing and Dr. Rajasekhara Reddy
40 Sabbasani, DST-SPARC 45.42
treating waste from urban water Co.PI:Dr. Anand Prabu A
resources
Trade Mark Protection of Colours in
India and the United Kingdom: Cross-
41 Dr. Usha S DST-SPARC 50.98
cultural Approaches, Advantages,
Obstacles, and Practical Utilities
Functionalisation of new Titanium
42 alloys after ECAP processing and Dr. Geetha Manivasagam DST-BRICS 39.13
surface treatment
Dr. Karthikeyan S,
IoT Forensics for detecting and B & B
43 Co.PI:Dr. Sasikumar P, 28.50
tracking construction material Industry
Dr. Samuel Rajkumar V
Android-based Intelligent Interactive
44 Home-based Monitoring System for Dr. Jayashree J ICMR-DHR 15.82
Predicting Diabetic Foot Ulcer
Anti-thrombotic super-hemophobic
45 Dr. Renold Elsen S DST-SPARC 50.22
surfaces
Fabrication of sheet nanoemulgel for
treating open surface wounds
46 particularly for subjects presenting Dr. Priyanka Srivastava DBT 11.00
delayed wound healing and pressure
sores
Development of Concentration
47 Gradient Microfluidic Needle Patch for Dr. Arun Kumar P, DBT 22.90
Combinatorial Diabetic Therapy Co.PI:Dr. Sushma Kumari
Development of unfolded protein
response (UPR) modulated HEK293
48 cells for improved recombinant Dr. Balaji Balakrishnan DBT 19.97
Adeno-associated virus (AAV)
production
Design of Heterobinuclear Ruthenium
49 (II) – Vanadium (IV) Complexes as Dr. Sheela A, CSIR 25.46
Co.PI:Dr. Priyankar Paira
Chemical Nucleases
103
www.vit.ac.in